Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (4): 6-16.doi: 10.6040/j.issn.1671-7554.0.2020.0491
Previous Articles Next Articles
YU Ying1, ZHANG Gong2, LIU Jing1, YAN Shitong1, HAN Tao1, HUANG Hailiang3
CLC Number:
[1] 中华人民共和国国家卫生健康委员会.截至2月27日24时新型冠状病毒感染的肺炎疫情最新情况 [EB/OL].(2020-03-31)[2020-02-03]. http://www.nhc.gov.cn/xcs/yqtb/202002/24a796819bf747bd8b94538451-7e9a51.shtml. [2] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020, 382(13): 1199-1207. [3] Gabutti G, Anchera E, Sandri F, et al. Coronavirus: update related to the current outbreak of COVID-19[J]. Infect Dis Ther, 2020, 9(2):1-13. [4] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. New Engl J Med, 2020, 382(8): 727-733. [5] Park JY, Ko JA, Kim DW, et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV[J]. J Enzyme Inhib Med Chem, 2016, 31(1): 23-30. [6] Riccio F, Talapatra SK, Oxenford S, et al. Development and validation of RdRp Screen, a crystallization screen for viral RNA-dependent RNA polymerases[J]. Biol Open, 2019, 8(1): 663. doi:10.1242/bio.037663. [7] 王晓东. 新型冠状病毒感染的肺炎中医药救治工作有序开展[J]. 世界中医药, 2020, 15(2): 285. [8] 中华人民共和国国家卫生健康委员会.关于印发新型冠状病毒感染的肺炎诊疗方案(试行第四版)的通知[EB/OL].(2020-01-27)[2020-01-29]. http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd-0785e67.shtml. [9] 张根荣.黄芪的现代药理研究及其临床应用[J].中国中医药现代远程教育, 2010, 8(23): 68. [10] 荆丰德.黄芪的药理作用与临床研究综述[J].实用医技杂志, 2008, 15(20): 2702-2704. [11] 任志萍.黄芪现代药理学研究进展[J].中国民族民间医药, 2010, 19(3): 35. [12] 宋宝辉,于新慧.黄芪对小鼠巨噬细胞、IL-2调节作用的影响[J].牡丹江医学院学报, 2005, 26(5): 10-11. SONG Baohui, YU Xinhui. Effects of Astragalus membranaceus on the regulation of macrophages and IL-2 in mice [J]. Journal of Mudanjiang Medical College, 2005, 26(5): 10-11. [13] Lauss M, Kriegner A, Vierlinger K, et al. Characterization of the drugged human genome[J]. Pharmacogenomics, 2007, 8(8): 1063-1073. [14] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. [15] 李艳超,白万柱,端川勉.潜在的神经侵袭特性可能是新型冠状病毒肺炎患者呼吸窘迫的原因之一[J].医学争鸣, 2020, 11(1): 7-10. LI Yanchao, BAI Wanzhu, Tsutomu H. Potential neuroinvasion may be one cause of respiratory distress in COVID-19 patients[J]. Negative, 2020, 11(1): 7-10. [16] Yu F, Du L, Ojcius DM, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China[J]. Microbes Infect, 2020, 22(2): 74-79. doi: 10.1016/j.micinf.2020.01.003. [17] Song Z, Xu Y, Bao L, et al. From SARS to MERS, thrusting coronaviruses into the spotlight[J].Viruses, 2019, 11(1): 59. doi: 10.3390/v11010059. [18] Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565-574. [19] Dubé M, Etienne L, Fels M, et al. Calcium-dependent rubella virus fusion occurs in early endosomes[J]. J Virol, 2016, 90(14): 6303-6313. [20] Chen X, Cao R, Zhong W. Host calcium channels and pumps in viral infections[J]. Cells, 2019, 9(1): 94. doi: 10.3390/cells9010094. [21] Kim TS, Shin EC. The activation of bystander CD8+ T cells and their roles in viral infection[J]. Exp Mol Med, 2019, 51(12): 1-9. [22] Baruah V, Bose S. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV[J]. J Med Virol, 2020, 92(5): 495-500. [23] Jiang J, Natarajan K, Margulies DH. MHC molecules, T cell receptors, natural killer cell receptors, and viral immunoevasins—key elements of adaptive and innate immunity[J]. Adv Exp Med Biol, 2019, 1172: 21-62. doi: 10.1007/978-981-13-9367-9_2. [24] 王树臻. cAMP直接激活蛋白Epac-1在病毒感染中的功能与机制研究[D].上海:华东师范大学, 2017. [25] Nuriev R, Johansson C. Chemokine regulation of inflammation during respiratory syncytial virus infection[J]. F1000Res, 2019, 8: F1000. doi: 10.12688/f1000resear-ch.20061.1. [26] 徐银胜,陈佳琛,盛望,等. 趋化因子及其受体在病毒性疾病中的作用[J].中华实验和临床病毒学杂志, 2012, 26(2): 153-155. [27] 文婕,殷少军.趋化因子及其受体在机体防御肺部感染中的作用[J].实用医学杂志, 2011, 27(18): 3426-3427. |
[1] | LI Mingbo, HUANG Yanbo, LIU Juncheng, REN Dongcheng, TAN Chengshuang, XU Jixi, DING Jinyong. Exploration of Huangqi Guizhi Wuwutang in the treatment of ankylosing spondylitis based on network pharmacology [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 29-38. |
[2] | FAN Xiaoyan, WANG Yuangeng, CHEN Zetao. Network pharmacologic mechanism of Huangqi Guizhi Wuwu Decoction in treating heart failure [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 70-81. |
[3] | Xi ZHOU,Muhan HUANG,Yujie REN,Yang QIU. SARS-CoV-2 infection, innate immunity and inflammatory response [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 15-21. |
[4] | LIU Zhong, ZHAO Mengjiao, YANG Guoliang, ZHAO Huailong, WANG Linlin, CHANG Caiyun, GENG Xingyi. Investigation of a COVID-19 case with unknown cause and its close contacts [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 49-53. |
[5] | YANG Liu, LI Zhan, XU Huaru, CHANG Caiyun, LIU Zhong, LI Chuanbin, SUN Zhan, JING Rui, LIU Tiecheng, GENG Xingyi, ZHOU Jingwen. Epidemiological and clinical characteristics of 10 children with coronavirus disease(COVID-19)in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 36-39. |
[6] | CHANG Caiyun, YU Qiuyan, ZHAO Xiaodong, WANG Fang, LI Wei, RUAN Shiman, GENG Xingyi. Epidemiological characteristics of the first COVID-19 case and related family cluster outbreaks in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 7-11. |
[7] | LI Xinrui, GENG Xingyi, ZHAO Xiaodong, LIU Lanzheng, WANG Weiru, CUI Liangliang, LI Zhan, CHANG Caiyun, RUAN Shiman. A comprehensive analysis of 47 COVID-19 cases in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 23-27. |
[8] | QIAO Yu, CUI Liangliang, LI Shuai, WANG Feng, RUAN Shiman, JING Yiming, LIU Chong. Research and development of intelligent question answering robot system: a case study of its application in response to COVID-19 epidemic in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 17-22. |
[9] | YUAN Yonggui, LI Lei, SHEN Zhongxia, CHEN Gang, WU Yigao, YUE Yingying. Prevention and control strategy for the diagnosis and treatment of psychiatric disorders during the epidemic of coronavirus disease 2019 [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 1-6. |
[10] | LI Xinrui, GENG Xingyi, WANG Weiru, ZHAO Xiaodong, LIU Lanzheng, ZHANG Xiaofei, LÜ Cuixia, CHANG Caiyun, LI Zhan, CUI Liangliang, RUAN Shiman. Consideration about cluster epidemic of 37 COVID-19 cases [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 32-40. |
[11] | CUI Liangliang, GENG Xingyi, ZHAO Xiaodong, YANG Guoliang, CHANG Caiyun, ZHAO Mengjiao, LI Zhan, WANG Chunrong, LIU Lanzheng, RUAN Shiman. Reflection and epidemiological characteristics of coronavirus disease 2019 in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 52-57. |
[12] | Consensus Group of Diagnosis and Treatment for Coronavirus Disease 2019, Qilu Hospital of Shandong University. Diagnosis, management, prevention and control for suspected cases of coronavirus disease 2019, Qilu Hospital criteria [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 1-7. |
[13] | HU Zhao, WANG Qiang. Coronavirus disease 2019 infection associated kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 26-31. |
[14] | Working Team of Prevention and Control for Coronavirus Disease 2019, Qilu Hospital of Shandong University. Strategy and practice of coronavirus disease 2019 prevention and control system in Qilu Hospital of Shandong University [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 8-18. |
[15] | YU Xueyuan, ZHANG Shuo, YAN Fangfang, SU Dezhen. Comparison of clinical efficacy of Qingfei Paidu decoction combined with western medicine in 43 cases and single western medicine in 46 cases in the treatment of COVID-19 [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 47-53. |
|